Literature DB >> 11686278

Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans.

P Mavroidis1, B K Lind, A Brahme.   

Abstract

Developments in radiation therapy planning have improved the information about the three-dimensional dose distribution in the patient. Isodose graphs, dose volume histograms and most recently radiobiological models can be used to evaluate the dose distribution delivered to the irradiated organs and volumes of interest. The concept of a biologically effective uniform dose (D) assumes that any two dose distributions are equivalent if they cause the same probability for tumour control or normal tissue complication. In the present paper the D concept both for tumours and normal tissues is presented, making use of the fact that probabilities averaged over both dose distribution and organ radiosensitivity are more relevant to the clinical outcome than the expected number of surviving clonogens or functional subunits. D can be calculated in complex target volumes or organs at risk either from the 3D dose matrix or from the corresponding dose volume histograms of the dose plan. The value of the D concept is demonstrated by applying it to two treatment plans of a cervix cancer. Comparison is made of the D concept with the effective dose (Deff ) and equivalent uniform dose (EUD) that have been suggested in the past. The value of the concept for complex targets and fractionation schedules is also pointed out.

Entities:  

Mesh:

Year:  2001        PMID: 11686278     DOI: 10.1088/0031-9155/46/10/307

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  15 in total

1.  A graphic user interface toolkit for specification, report and comparison of dose-response relations and treatment plans using the biologically effective uniform dose.

Authors:  Fan-Chi Su; Panayiotis Mavroidis; Chengyu Shi; Brigida Costa Ferreira; Niko Papanikolaou
Journal:  Comput Methods Programs Biomed       Date:  2010-03-24       Impact factor: 5.428

2.  Tradeoffs for assuming rigid target motion in Mlc-based real time target tracking radiotherapy: a dosimetric and radiobiological analysis.

Authors:  T Roland; C Shi; Y Liu; R Crownover; P Mavroidis; N Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2010-04

3.  Evaluation on lung cancer patients' adaptive planning of TomoTherapy utilising radiobiological measures and Planned Adaptive module.

Authors:  Fan-Chi Su; Chengyu Shi; Panayiotis Mavroidis; Prema Rassiah-Szegedi; Niko Papanikolaou
Journal:  J Radiother Pract       Date:  2009-01-01

4.  Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.

Authors:  P Mavroidis; C Shi; G A Plataniotis; M G Delichas; B Costa Ferreira; S Rodriguez; B K Lind; N Papanikolaou
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

5.  Incorporating system latency associated with real-time target tracking radiotherapy in the dose prediction step.

Authors:  Teboh Roland; Panayiotis Mavroidis; Chengyu Shi; Nikos Papanikolaou
Journal:  Phys Med Biol       Date:  2010-04-19       Impact factor: 3.609

6.  Assessing four-dimensional radiotherapy planning and respiratory motion-induced dose difference based on biologically effective uniform dose.

Authors:  F-C Su; C Shi; P Mavroidis; V Goytia; R Crownover; P Rassiah-Szegedi; N Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2009-06

7.  Consequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.

Authors:  Panayiotis Mavroidis; Drosoula Giantsoudis; Musaddiq J Awan; Jasper Nijkamp; Coen R N Rasch; Joop C Duppen; Charles R Thomas; Paul Okunieff; William E Jones; Lisa A Kachnic; Niko Papanikolaou; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2014-07-01       Impact factor: 6.280

8.  Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma.

Authors:  Jin Wang; Yuan-Yuan Chen; An Tai; Xue-Lin Chen; Shao-Ming Huang; Cungen Yang; Yong Bao; Ning-Wei Li; Xiao-Wu Deng; Chong Zhao; Ming Chen; X Allen Li
Journal:  Transl Oncol       Date:  2015-12       Impact factor: 4.243

9.  Radiobiologically based treatment plan evaluation for prostate seed implants.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Carlos Esquivel; Dimos Baltas; Sotirios Stathakis; Gregory Swanson; Nikos Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-07-06

10.  Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Sotirios Stathakis; Mark Smith; Gregory Swanson; Niko Papanikolaou
Journal:  J Contemp Brachytherapy       Date:  2011-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.